Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 192

Similar articles for PubMed (Select 24461315)

1.

Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients.

Askari F, Rashidkhani B, Hekmatdoost A.

Nutr Res. 2014 Feb;34(2):143-8. doi: 10.1016/j.nutres.2013.11.005. Epub 2013 Dec 6.

PMID:
24461315
2.

Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease.

Kawanaka M, Nishino K, Oka T, Urata N, Nakamura J, Suehiro M, Kawamoto H, Chiba Y, Yamada G.

Hepat Med. 2015 Jun 3;7:29-35. doi: 10.2147/HMER.S79100. eCollection 2015.

3.

Efficacy of poly-unsaturated fatty acid therapy on patients with nonalcoholic steatohepatitis.

Li YH, Yang LH, Sha KH, Liu TG, Zhang LG, Liu XX.

World J Gastroenterol. 2015 Jun 14;21(22):7008-13. doi: 10.3748/wjg.v21.i22.7008.

4.

Neutrophil-to-lymphocyte ratio is not a predictor of liver histology in patients with nonalcoholic fatty liver disease.

Kara M, Dogru T, Genc H, Sertoglu E, Celebi G, Gurel H, Kayadibi H, Cicek AF, Ercin CN, Sonmez A.

Eur J Gastroenterol Hepatol. 2015 Jun 6. [Epub ahead of print]

PMID:
26062078
5.

[Treating non-alcoholic fatty liver disease patients of Gan stagnation Pi deficiency syndrome by tiaogan lidi recipe: a randomized controlled clinical trial].

Yu Q, Zhang SS, Zhou T, Xiong Y, Zhao LQ, Ding Y.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2015 Apr;35(4):401-5. Chinese.

PMID:
26043560
6.

Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

Gangarapu V, Ince AT, Baysal B, Kayar Y, Klç U, Gök Ö, Uysal Ö, Şenturk H.

Eur J Gastroenterol Hepatol. 2015 Jul;27(7):840-5. doi: 10.1097/MEG.0000000000000348.

PMID:
26043290
7.

A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.

Choi SH, Oh DJ, Kwon KH, Lee JK, Koh MS, Lee JH, Kang HW.

Turk J Gastroenterol. 2015 Jun 2. doi: 10.5152/tjg.2015.0046. [Epub ahead of print]

PMID:
26039004
8.

Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.

Chen S, Zhao X, Wan J, Ran L, Qin Y, Wang X, Gao Y, Shu F, Zhang Y, Liu P, Zhang Q, Zhu J, Mi M.

Pharmacol Res. 2015 May 30;99:74-81. doi: 10.1016/j.phrs.2015.05.009. [Epub ahead of print]

PMID:
26032587
9.

A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.

Pacifico L, Bonci E, Di Martino M, Versacci P, Andreoli G, Silvestri LM, Chiesa C.

Nutr Metab Cardiovasc Dis. 2015 Apr 25. pii: S0939-4753(15)00103-9. doi: 10.1016/j.numecd.2015.04.003. [Epub ahead of print]

PMID:
26026214
10.

Intrahepatic transplantation of adipose‑derived stem cells attenuates the progression of non‑alcoholic fatty liver disease in rats.

Pan F, Liao N, Zheng Y, Wang Y, Gao Y, Wang S, Jiang Y, Liu X.

Mol Med Rep. 2015 May 26. doi: 10.3892/mmr.2015.3847. [Epub ahead of print]

PMID:
26018346
11.

A CONSORT-Compliant, Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Purified Anthocyanin in Patients With Nonalcoholic Fatty Liver Disease.

Zhang PW, Chen FX, Li D, Ling WH, Guo HH.

Medicine (Baltimore). 2015 May;94(20):e758. doi: 10.1097/MD.0000000000000758.

PMID:
25997043
12.

Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease.

Chang CC, Wu CL, Su WW, Shih KL, Tarng DC, Chou CT, Chen TY, Kor CT, Wu HM.

Sci Rep. 2015 May 11;5:10096. doi: 10.1038/srep10096.

13.

High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.

Portillo-Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, Subbarayan S, Webb A, Hecht J, Cusi K.

J Clin Endocrinol Metab. 2015 Jun;100(6):2231-8. doi: 10.1210/jc.2015-1966. Epub 2015 Apr 17.

PMID:
25885947
14.

[Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis].

Shi T, Zhuang R, Zhou H, Wang F, Shao Y, Cai Z.

Zhonghua Gan Zang Bing Za Zhi. 2015 Feb;23(2):124-9. doi: 10.3760/cma.j.issn.1007-3418.2015.02.010. Chinese.

PMID:
25880979
15.

Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial.

Bae JC, Lee WY, Yoon KH, Park JY, Son HS, Han KA, Lee KW, Woo JT, Ju YC, Lee WJ, Cho YY, Lee MK.

Diabetes Care. 2015 Jul;38(7):1245-52. doi: 10.2337/dc14-2852. Epub 2015 Apr 15.

PMID:
25877813
16.

The effect of berberis vulgaris extract on transaminase activities in non-alcoholic Fatty liver disease.

Iloon Kashkooli R, Najafi SS, Sharif F, Hamedi A, Hoseini Asl MK, Najafi Kalyani M, Birjandi M.

Hepat Mon. 2015 Feb 5;15(2):e25067. doi: 10.5812/hepatmon.25067. eCollection 2015 Feb.

17.

Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.

Janczyk W, Lebensztejn D, Wierzbicka-Rucińska A, Mazur A, Neuhoff-Murawska J, Matusik P, Socha P.

J Pediatr. 2015 Jun;166(6):1358-1363.e3. doi: 10.1016/j.jpeds.2015.01.056. Epub 2015 Mar 11.

PMID:
25771388
18.

Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoholic fatty liver disease: a pilot trial.

Oh S, Maruyama T, Eguchi K, Shida T, Arai E, Isobe T, Okamoto Y, Shoda J.

Ther Clin Risk Manag. 2015 Mar 4;11:371-80. doi: 10.2147/TCRM.S75109. eCollection 2015.

19.

Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled Trial.

Shenoy KT, Balakumaran LK, Mathew P, Prasad M, Prabhakar B, Sood A, Singh SP, Rao NP, Zargar SA, Bignamini AA.

J Clin Exp Hepatol. 2014 Jun;4(2):94-100. doi: 10.1016/j.jceh.2014.03.041. Epub 2014 Mar 27.

20.

Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report.

Cuschieri JR, John BK, Miick R, Ortiz JA, Hashemi N.

J Clin Exp Hepatol. 2013 Mar;3(1):70-4. doi: 10.1016/j.jceh.2013.01.001. Epub 2013 Jan 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk